• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Shanghai's life-saving efforts against the current omicron wave of the COVID-19 pandemic.

作者信息

Zhang Xinxin, Zhang Wenhong, Chen Saijuan

机构信息

Department of Infectious Diseases, Research Laboratory of Clinical Virology, National Research Center for Translational Medicine, Shanghai, China; Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.

Department of Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Huashan Hospital, Fudan University School of Medicine, Shanghai, China.

出版信息

Lancet. 2022 May 28;399(10340):2011-2012. doi: 10.1016/S0140-6736(22)00838-8. Epub 2022 May 6.

DOI:10.1016/S0140-6736(22)00838-8
PMID:35533708
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9075855/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70a4/9075855/3d390657ea05/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70a4/9075855/3d390657ea05/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70a4/9075855/3d390657ea05/fx1_lrg.jpg

相似文献

1
Shanghai's life-saving efforts against the current omicron wave of the COVID-19 pandemic.上海针对当前新冠疫情奥密克戎毒株浪潮所做出的拯救生命的努力。
Lancet. 2022 May 28;399(10340):2011-2012. doi: 10.1016/S0140-6736(22)00838-8. Epub 2022 May 6.
2
Shanghai's Response to Fast Spreading of the COVID-19 Pandemic-Omicron (B.2).上海对新冠疫情奥密克戎毒株（B.2）快速传播的应对措施
Asia Pac J Public Health. 2022 Nov;34(8):843-845. doi: 10.1177/10105395221124278. Epub 2022 Sep 9.
3
How Shanghai's scientists are coping amid harsh COVID lockdown.上海的科学家们在新冠疫情封锁的严峻形势下是如何应对的。
Nature. 2022 Apr;604(7906):409-410. doi: 10.1038/d41586-022-01052-z.
4
Editorial: The 2022 World Health Organization (WHO) Priority Recommendations and Response to the Omicron Variant (B.1.1.529) of SARS-CoV-2.社论：2022 年世界卫生组织（WHO）关于 SARS-CoV-2 奥密克戎变异株（B.1.1.529）的优先推荐意见和应对措施。
Med Sci Monit. 2022 Feb 1;28:e936199. doi: 10.12659/MSM.936199.
5
The SARS-CoV-2 omicron wave is indicating the end of the pandemic phase but the COVID-19 will continue.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）奥密克戎毒株引发的疫情浪潮预示着大流行阶段即将结束，但新冠疫情仍将持续。
J Med Virol. 2022 Jun;94(6):2343-2345. doi: 10.1002/jmv.27635. Epub 2022 Feb 4.
6
Transplantation in India and China during the COVID-19 pandemic.新冠疫情期间印度和中国的移植情况。
Lancet Public Health. 2022 Jan;7(1):e12. doi: 10.1016/S2468-2667(21)00280-2.
7
Commentary: China's Zero-COVID Approach Depends on Shanghai's Outbreak Control.评论：中国的动态清零政策取决于上海的疫情防控。
Front Public Health. 2022 Jun 14;10:912992. doi: 10.3389/fpubh.2022.912992. eCollection 2022.
8
Fever clinics in China at the early stage of the COVID-19 pandemic.新冠疫情初期中国的发热门诊。
Int J Clin Pract. 2021 May;75(5):e14125. doi: 10.1111/ijcp.14125.
9
COVID-19 Pandemic: Experiences in China and Implications for its Prevention and Treatment Worldwide.COVID-19 大流行：中国的经验及其对全球预防和治疗的启示。
Curr Cancer Drug Targets. 2020;20(6):410-416. doi: 10.2174/1568009620666200414151419.
10
[Progress in research of 2019-nCoV Omicron variant].[2019新型冠状病毒奥密克戎变异株的研究进展]
Zhonghua Liu Xing Bing Xue Za Zhi. 2022 May 10;43(5):655-662. doi: 10.3760/cma.j.cn112338-20220121-00061.

引用本文的文献

1
Retrospective Analysis of Factors Associated with a Prolonged Nucleic Acid Conversion Time in Patients with COVID-19 at Fangcang Shelter Hospital.方舱医院新冠肺炎患者核酸转阴时间延长相关因素的回顾性分析
Infect Drug Resist. 2025 Jun 30;18:3219-3229. doi: 10.2147/IDR.S521808. eCollection 2025.
2
Dynamic and classifier-based model SARS-CoV-2 Omicron spillover risk assessment in China.基于动态和分类器的中国新冠病毒奥密克戎毒株溢出风险评估模型
Fundam Res. 2023 May 7. doi: 10.1016/j.fmre.2023.03.014.
3
Advancing pathogen detection for airborne diseases.
推进空气传播疾病的病原体检测。
Fundam Res. 2022 Oct 31;3(4):520-524. doi: 10.1016/j.fmre.2022.10.011. eCollection 2023 Jul.
4
Mental Health Concerns in Patients with COVID-19: A Network Analysis.新型冠状病毒肺炎患者的心理健康问题：一项网络分析。
Psychol Res Behav Manag. 2025 May 17;18:1125-1137. doi: 10.2147/PRBM.S524256. eCollection 2025.
5
Myeloid-Driven Immune Suppression Subverts Neutralizing Antibodies and T Cell Immunity in Severe COVID-19.髓系驱动的免疫抑制破坏了重症 COVID-19 中的中和抗体和 T 细胞免疫。
J Med Virol. 2025 Apr;97(4):e70335. doi: 10.1002/jmv.70335.
6
Effectiveness of inactivated COVID-19 vaccine against symptom severity in hospitalized COVID-19 patients infected with the Omicron variant.新冠病毒灭活疫苗对感染奥密克戎变异株的住院新冠肺炎患者症状严重程度的有效性
Arch Virol. 2025 Mar 24;170(5):88. doi: 10.1007/s00705-025-06275-9.
7
Protection afforded by post-infection SARS-CoV-2 vaccine doses: A cohort study in Shanghai.感染后接种新冠病毒疫苗剂量所提供的保护：上海的一项队列研究
Elife. 2025 Feb 17;13:RP94990. doi: 10.7554/eLife.94990.
8
Resurgence of common respiratory viruses and mycoplasma pneumoniae after ending the zero-COVID policy in Shanghai.上海结束新冠清零政策后常见呼吸道病毒和肺炎支原体的再现。
Sci Rep. 2025 Jan 13;15(1):1765. doi: 10.1038/s41598-025-85852-z.
9
COVID-19 outbreaks caused by different SARS-CoV-2 variants: a descriptive, comparative study from China.由不同严重急性呼吸综合征冠状病毒2（SARS-CoV-2）变体引起的2019冠状病毒病（COVID-19）疫情：来自中国的一项描述性比较研究
Front Public Health. 2024 Dec 12;12:1416900. doi: 10.3389/fpubh.2024.1416900. eCollection 2024.
10
Prevalence of cardiovascular risk factors according to Life's Essential 8 in children and adolescents during the COVID-19 pandemic: A systematic review and meta-analysis including 1 526 173 participants from 42 countries.新冠疫情期间儿童和青少年基于生命八大要素的心血管危险因素患病率：一项系统综述和荟萃分析，纳入来自42个国家的1526173名参与者
Pediatr Obes. 2025 Jan;20(1):e13190. doi: 10.1111/ijpo.13190. Epub 2024 Nov 29.